Journal profile · Pediatrics
Pediatric Transplantation
ISSN 1397-3142 · eISSN 1399-3046 · Wiley-Blackwell Publishing Ltd · DENMARK · Bimonthly · Founded 1997
Pediatric Transplantation: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.4; hybrid open access; APC about USD 3,730; median 127 days to acceptance (109 articles, last 24 months); community-reported acceptance: easy; 262 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Pediatric Transplantation is published by Wiley-Blackwell Publishing Ltd and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Renal Transplantation Outcomes and Treatments, Organ Transplantation Techniques and Outcomes and Transplantation: Methods and Outcomes, together about 41.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The aim of Pediatric Transplantation is to publish original articles of the highest quality on clinical experience and basic research in transplantation of tissues and solid organs in infants, children and adolescents. The journal seeks to disseminate the latest information widely to all individuals involved in kidney, liver, heart, lung, intestine and stem cell (bone-marrow) transplantation. In addition, the journal publishes focused reviews on topics relevant to pediatric transplantation as well as timely editorial comment on controversial issues. The scope of the journal includes involving clinical research, case-reports delineating universal clinical consequences and basic transplant immunobiology related to pediatric transplantation. Each issue contains Pediatric Transplant Grand Rounds which comprise reports from institutions worldwide aimed at sharing pertinent clinical information with those caring for pediatric transplant recipients. The publication of a journal devoted to transplantation in infants, children and adolescents is extremely important because of the increasing clinical use of tissue and organ transplantation to resolve catastrophic circumstances not amenable to other therapeutic approaches. The journal serves the needs of pediatricians, pediatric surgeons, transplant surgeons, pediatric urologists, pediatric nephrologists, pediatric gastroenterologists, pediatric cardiologists, pediatric pulmonologists and pediatric haematologists/oncologists, all of whom will find great advantage in the timely updated information offered by the journal.
From the journal's Aims & Scope
Research area (LetPub): Pediatrics
Editor-in-chief Sharon M. BartoshPublisher website
Editorial board by country: none in mainland China; most named United States 60, Germany 11, Canada 8, United Kingdom 5, Australia 3 (108 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Renal Transplantation Outcomes and TreatmentsMedicine16.1%
- Organ Transplantation Techniques and OutcomesMedicine14.8%
- Transplantation: Methods and OutcomesMedicine10.1%
- Liver Disease and TransplantationMedicine7.6%
- Hematopoietic Stem Cell TransplantationMedicine5%
- Organ Donation and TransplantationMedicine4.3%
- Cytomegalovirus and herpesvirus researchMedicine4%
- Polyomavirus and related diseasesMedicine3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pediatrics | Zone 4 |
| Minor | Transplantation | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pediatrics | Zone 4 |
| Minor | Transplantation | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pediatrics | Zone 4 |
| Minor | Transplantation | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCASCurrent ContentsPublisher website
Other: EBSCO
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.4LetPub ·
- Impact factor (publisher)
- 1.4Publisher website ·
- Impact factor (publisher) 2025
- 1.4Publisher website ·
- CiteScore 2026-06
- 2.7LetPub ·
- CiteScore (publisher)
- 2.7Publisher website ·
- CiteScore (publisher) 2025
- 2.7Publisher website ·
- SJR 2026-06
- 0.53LetPub ·
- SNIP 2026-06
- 0.66LetPub ·
- h-index
- 63LetPub ·
- h-index
- 89OpenAlex ·
- i10-index
- 2,424OpenAlex ·
- 2-year mean citedness
- 1.39OpenAlex ·
- Self-citation rate
- 21.4%LetPub ·
- Share of gold OA articles
- 28.91%LetPub ·
Volume
- Articles per year
- 213LetPub ·
- Articles per year (publisher) 2025
- 240Publisher website ·
- Downloads per year (publisher) 2025
- 312,083Publisher website ·
Articles by year OpenAlex count · 5,745 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 213 | 121 | 42 |
| 2025 | 262 | 131 | 296 |
| 2024 | 244 | 147 | 661 |
| 2023 | 230 | 132 | 965 |
| 2022 | 248 | 74 | 1,456 |
| 2021 | 266 | 68 | 1,762 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
127 daysMedian, submission to acceptance · P25–P75 77 days – 189 days
- Acceptance to online
- median 13 days (109 articles)
- Submission to online
- median 147 days
- Sample
- 109 articles with submission and acceptance dates (512 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Acceptance rate (publisher)
- 54%Publisher website ·
- Acceptance rate (publisher) 2025
- 54%Publisher website ·
- Submission to first decision
- 42 daysPublisher website ·
- Submission to first decision 2025
- 42 daysPublisher website ·
- Submission to acceptance 2025
- 139 daysPublisher website ·
- Acceptance to publication 2025
- 12 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,730 / EUR 3,130 / GBP 2,440 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Reference style
- Numbered, in order of citation
- Graphical abstract
- Required
- Cover letter
- Optional
Article types accepted13
- book reviewBook Review 650 N/A 10 0Length not stated
- brief communicationBrief Communication 3000 250 30 N/ALength not stated
- case reportCase Report 3000 250 30 N/ALength not stated
- comprehensive reviewComprehensive Review 6000 250 N/A N/ALength not stated
- editorialEditorial 800 N/A 10 1Length not stated
- global forumGlobal Forum 5000 250 N/A N/ALength not stated
- letter to the editorLetter to the Editor 500 N/A 5 1Length not stated
- meeting reportMeeting Report 3000 250 50 5Length not stated
- minireviewMinireview 3000 250 40 3Length not stated
- original articleOriginal Article 5000 250 N/A N/ALength not stated
- personal viewpointPersonal Viewpoint 3000 250 30 3Length not stated
- research noteResearch Note 900 N/A 10 2Length not stated
- special articleSpecial Article 5000 250 N/A N/ALength not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, Peer review, Trial registration / reporting guidelines
- AI use Generative AI
Artificial Intelligence Generated Content (AIGC) tools—such as ChatGPT and others based on large language models (LLMs)—cannot be considered capable of initiating an original piece of research without direction by human authors. They also cannot be accountable for a published work or for research design, which is a generally held requirement of authorship (as discussed in the previous section), no…
Source ↗Publisher website ·- Authorship Authorship
The journal follows the ICMJE definition of authorship, which indicates that authorship be based on the following 4 criteria:
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest
The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potent…
Source ↗Publisher website ·- Data availability Data Sharing and Data Accessibility
Data sharing expected in public repositories; data accessibility statement required. Model summary
The journal expects that data supporting the results in the paper will be archived in an appropriate public repository. Whenever possible the scripts and other artefacts used to generate the analyses presented in the paper should also be publicly archived. Exceptions may be granted at the discretion of the editor for sensitive information such as human subject data or the location of endangered sp…
Source ↗Publisher website ·- Publication ethics Publication Ethics
COPE member; uses iThenticate CrossCheck for overlapping/similar text detection. Model summary
This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley’s Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.
Source ↗Publisher website ·- Peer review Peer Review and Acceptance
Peer review with editor screening for quality and relevance. Model summary
The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Except where otherwise stated, manuscripts are peer reviewed. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectivel…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- DENMARK
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1997
- ISSN
- 1397-3142
- Electronic ISSN
- 1399-3046
- Society / sponsor
- IPTA
- Latest issue on the website
- Volume 30, Issue 9 (September 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Pediatric Transplantation
What CAS zone is Pediatric Transplantation in?
In the 2025 upgraded edition of the CAS Journal Ranking, Pediatric Transplantation is in Zone 4 of Medicine, and in Zone 4 of the minor category Pediatrics / Transplantation. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Pediatric Transplantation?
The latest impact factor listed by LetPub is 1.4; CiteScore 2.7, h-index 89.
How long does peer review take at Pediatric Transplantation?
Based on the dates recorded on 109 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 127 days (interquartile range 77–189 days); authors report an average review time of 3–8 weeks; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 54% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Pediatric Transplantation?
According to the journal's author guidelines: Reference style: Numbered, in order of citation; Graphical abstract: Required; Cover letter: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Pediatric Transplantation based?
Of the 108 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (60), Germany (11) and Canada (8). Counted from the institutions listed on the board page; for reference only.
Which databases index Pediatric Transplantation?
According to LetPub and DOAJ records, Pediatric Transplantation is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Pediatric Transplantation open access, and what is the APC?
Pediatric Transplantation is a hybrid journal. For open-access publication: APC about USD 3,730.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .